An interventional study of 3D printed (3DP) bone models + CT imaging and CT imaging in Distal Humerus Fracture, Distal Femur Fracture and Distal Tibia Fracture, sponsored by The University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-20.
Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to compare the effectiveness of 3D-printed bone models in addition to CT imaging versus CT imaging alone on surgical quality and operation time for patients undergoing surgical repair of intra-articular fractures.
Surgical fixation of intra-articular fractures is a technically demanding task that poses significant challenges to orthopaedic surgeons. Articular fragments may be comminuted, depressed, or impacted, and neighbouring soft tissue is often heavily compromised. Furthermore, aggressive surgical dissection is typically necessary to achieve adequate visualisation, and anatomical reduction often devitalises bone fragments and invites deep infection. The management of intra-articular fractures requires a well-designed preoperative plan and a skilfully executed surgical tactic to guarantee the best possible outcome. Multiplanar reformation (CT-MPR) and three-dimensional reconstruction (CT-3DR) are imaging techniques that have enhanced intraoperative visualisation, however, accurate analysis of complex fractures remains challenging.
3D printing is a rapidly developing, low-cost technology that is already being applied across numerous contexts in orthopaedics and traumatology. 3D printed bone models can be produced from digitised CT data in a matter of hours, providing a dimensionally accurate representation of the patient's skeleton which approximates real-life visual and tactile experiences. When used in preoperative planning, these models have shown to improve surgeon communication and shorten surgical duration. Despite positive early results, few clinical studies have studied the effect of 3D bone model use on surgical outcome. The purpose of this randomised controlled trial is to compare the effectiveness of intraoperatively utilised 3D bone models in addition to conventional CT imaging on reduction quality and surgical duration versus CT imaging alone for patients undergoing surgical fixation of complex intraarticular fractures.
Patients providing informed consent will be screened for eligibility. All eligible patients will be randomly assigned in a double-blind manner (participant and outcome assessor) to receive surgical fracture fixation with or without the addition of sterilised 3D-printed bone models to standard CT imaging for intraoperative visualisation.
31 studies on the registry are indexed under Femoral Fractures, Distal; 11 are open to participants now.
This study's planned enrollment of 80 is close to the median of 81 across 22 interventional studies indexed under Femoral Fractures, Distal.
Browse Femoral Fractures, Distal studies →The University of Hong Kong is the lead sponsor of 1,295 studies on the registry; 351 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Fracture repair surgery using sterilized 3DP models, CT-MPR and CT-3DR for planning and intraoperative visualization
Other: 3D printed (3DP) bone models + CT imaging
Fracture repair surgery using CT-MPR and CT-3DR for planning and intraoperative visualization
Other: CT imaging
In addition to CT-MPR and CT-3DR, 3DP models will be used for surgical planning and intraoperative visualization.
CT-MPR and CT-3DR used for surgical planning and intraoperative visualization.
Quality of articular surface reduction grading assessed by three-point scale
The quality of articular surface reduction will be rated by two surgeons blinded to intervention allotment assessing post-operative and intraoperative fluoroscopic images. The Kappa value will be recorded for inter-observer agreement between two observers (1. Perfect reduction, 2. Observable imperfections 1-2mm, 3. Significant imperfections \>2mm)
Time frame: Immediately post-operation
Skin to skin duration of surgery (minutes)
The skin to skin duration of the surgery will be recorded.
Time frame: Immediately post-operation
Total fluoroscopy time (seconds)
The total intraoperative fluoroscopy time will be recorded in seconds.
Time frame: Immediately post-operation
Intraoperative blood loss (mL)
The patient's blood loss during the surgery will be recorded.
Time frame: Immediately post-operation
Total length of skin incision (mm)
The total length on the incision will be measured post operation.
Time frame: Immediately post-operation
Total tourniquet time (minutes)
Total time the tourniquet was applied will be recorded.
Time frame: Immediately post-operation
Incidence of surgical complications
Incidence of infection, neurological deficit, wound breakdown, loss of fixation, revision surgery will be recorded at follow up.
Time frame: 3 months post-operation
Quality of articular surface reduction grading assessed by three-point scale
The quality of articular surface reduction will be rated by two surgeons blinded to intervention allotment assessing post-operative and intraoperative fluoroscopic images. The Kappa value will be recorded for inter-observer agreement between two observers (1. Perfect reduction, 2. Observable imperfections 1-2mm, 3. Significant imperfections \>2mm)
Time frame: 3 months post operation
Health-related quality of life measured by SF-12 Chinese (HK) version
12-item Short Form Health Survey (SF-12), a patient-reported outcome measure of HRQOL comprised of a mental component (MCS) and physical component (PCS), each with a final score ranging from 0 (worst outcome) to 100 (best outcome).
Time frame: 3 months post-operation
Plan to share: Yes — Anonymized dataset to be included as supplementary data in final publication
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Within 1 year of study completion
Access criteria: Additional information available upon reasonable request of principal investigator
Started Mar 2020 (actual). Primary completion is estimated for Dec 2023, 45 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.